| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, and aims at preventing and treating cachexia. There are used combined beta-adrenergic antagonist and 5-HT1a partial agonists or antagonists selected from the group consisting of (S)-pindolol and (S)-propranolol, or salts thereof.EFFECT: method enables reducing cachexia-related body weight loss.15 cl, 1 ex, 1 tbl |
